Amador Bioscience provides global translational research and clinical development solutions. With established sites in the United States, Europe, and China, Amador confidently meets international clinical trial quality and compliance standards. We enhance the success rate of new drugs in any regulatory setting and take innovative drug development projects from pre-clinical research and development to market approval.
Specific Areas of Activity
What do we do?
Amador Bioscience is a global, next-generation contract research organization (CRO). We specialize in providing various services, solutions, deep expertise, and a wide breadth of experience in translational research and clinical development projects.
For what type of studies?
Our services are tailored for a wide range of non-clinical to Phase IV studies, including but not limited to genetic research, molecular biology, bioinformatics, drug discovery, diagnostic development, and biomarker identification.
Who are our clients?
Our clients include academic institutions, research laboratories, pharmaceutical companies, biotechnology firms, healthcare organizations, and government agencies. We collaborate with scientists, researchers, and professionals who require expertise and support in their drug development projects.
Key areas of focus
Data Management – Early Clinical Phases – Laboratory – Late phase IV – Medical Writing – Pharmacometrics (Modeling&Simulation) – Pharmacovigilance & Drug – Preclinical – Project Management – Regulatory – Safety – Statistics
Regional Director, EMEA